Preliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506).
作者信息
PAPAC R, GALTON D A, TILL M, WILTSHAW E
出版信息
Ann N Y Acad Sci. 1958 Apr 24;68(3):1126-7. doi: 10.1111/j.1749-6632.1958.tb42674.x.
Abstract
摘要
相似文献
1
Preliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506).
Ann N Y Acad Sci. 1958 Apr 24;68(3):1126-7. doi: 10.1111/j.1749-6632.1958.tb42674.x.
2
P-(Di-2-chloroethyl) aminophenylbutyric acid (CB 1348) in the treatment of cancer.
Ann N Y Acad Sci. 1958 Apr 24;68(3):1017. doi: 10.1111/j.1749-6632.1958.tb42658.x.
3
Early experience with p-(N, N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia.
Cancer. 1956 May-Jun;9(3):512-7. doi: 10.1002/1097-0142(195605/06)9:3<512::aid-cncr2820090312>3.0.co;2-o.
4
Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.氨基葡萄糖氮芥类抗癌剂对小鼠的抗肿瘤活性及骨髓毒性
Cancer Res. 1986 May;46(5):2340-3.
5
[Clinical study of the antineoplastic effect of DL-p-bis(beta-chloroethyl) aminophenylalanine].
Minerva Med. 1956 Aug 11;47(63-64):340-2.
6
Studies of phenylalanine nitrogen mustard (CB 3025) in metastatic malignant melanoma of man.
Ann N Y Acad Sci. 1958 Apr 24;68(3):1122-5. doi: 10.1111/j.1749-6632.1958.tb42673.x.
7
Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia.
Acta Radiol (Stockh). 1957 Mar;47(3):210-16. doi: 10.3109/00016925709170889.
8
Effect of phenylalanine nitrogen mustard on tissues in culture.
Antibiot Chemother (Northfield). 1957 Sep;7(9):493-6.
9
Clinical experience with the use of R48 (NN-di-2'-chloroethyl-2'-naphthylamine).
Ann N Y Acad Sci. 1958 Apr 24;68(3):1116-21. doi: 10.1111/j.1749-6632.1958.tb42672.x.
10
Nitrogen and phenylalanine mustard. Use in women with intrauterine cancer.
Am J Obstet Gynecol. 1962 Feb 15;83:490-3. doi: 10.1016/0002-9378(62)90583-5.
引用本文的文献
1
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens.大样本自体和异基因造血细胞移植受者中马法兰的群体药代动力学：向个体化给药方案迈进。
Clin Pharmacokinet. 2022 Apr;61(4):553-563. doi: 10.1007/s40262-021-01093-z. Epub 2021 Dec 2.
2
Biochemical studies with methanesulphonyl esters, especially beta-chloroethyl methanesulphonate.用甲磺酸酯进行的生化研究，特别是β-氯乙基甲磺酸酯。
Biochem J. 1960 Oct;77(1):186-94. doi: 10.1042/bj0770186.
3
ORAL MELPHALAN THERAPY IN ADVANCED MALIGNANT DISEASE.
Br J Cancer. 1963 Sep;17(3):381-90. doi: 10.1038/bjc.1963.53.
4
Chemotherapy of cancer.癌症的化学疗法。
Postgrad Med J. 1958 Dec;34(398):622-7. doi: 10.1136/pgmj.34.398.622.
5
Cancer chemotherapy: past, present, and future--Part I.癌症化疗：过去、现在与未来——第一部分
J Natl Med Assoc. 1984 Aug;76(8):773-84.
Zotero 插件